Le Lézard
Classified in: Health
Subjects: PDT, CSR

St. George's University Launches $10 Million Humanitarian Scholarship Fund


ST. GEORGE, Grenada, Oct. 18, 2017 /PRNewswire/ --Today, St. George's University announced the creation of a $10 million scholarship fund for students interested in humanitarian work. Students may receive individual partial-tuition awards averaging $30,000.

"Social outreach and humanitarian work are central to our mission here at St. George's," said Dr. G. Richard Olds, president of St. George's University. "From Grenada to the thousands of hospitals and clinics worldwide where our graduates work, we've always sought to provide top-notch care to those in need. This scholarship fund will enable more students to pursue their passions for helping the underprivileged."

All students applying for admission for the January sessions will be automatically considered for the Humanitarian Scholarship. Eligible applicants will be evaluated based on their backgrounds in humanitarian work, such as dedicated work in Vistra, the Peace Corps, Habitat for Humanity, medical missions, or volunteer positions in community organizations ? all activities that show a dedication to improving the general welfare of mankind and its communities.

The Humanitarian Scholarship is one of many awards currently available to St. George's students. The Legacy of Excellence Scholarship Program, for example, offers partial-tuition scholarships to students with strong academic records. CityDoctors scholarships are awarded to students who intend to practice in urban communities after graduation.

"We work hard to make medical school a feasible option for each and every one of our applicants," Dr. Olds added. "The more scholarships we can offer, the more diverse and well-rounded our student body will be."

About St. George's University
St. George's University is a center of international education, drawing students and faculty from 140 countries to the island of Grenada, in the West Indies, to its programs in medicine, veterinary medicine, public health, science, social science, information technology, and business. St. George's is affiliated with educational institutions worldwide, including in the United States, the United Kingdom, Canada, Australia, and Ireland. The University's over 17,000 graduates include physicians, veterinarians, scientists, and public health and business professionals across the world. The University's programs are accredited and approved by many governing authorities and repeatedly recognized as the best in the region. For more information, visit www.sgu.edu.

Media Contact:
Yael Wollstein
(202) 471-4228 ext 118
[email protected]

SOURCE St. George's University


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: